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Abstract: There is increasing interest in using natural products as anticancer agents, as many 
have antioxidative properties that may help to prevent cellular damage that can lead to cancer. 
In addition, there is the expectation that many natural products will have low toxicity and few 
side effects. However, most anticancer and antioxidative agents are hydrophobic, reducing their 
bioavailability in vivo and making them problematic to deliver. Curcumin provides a good model 
system for study. In low doses it shows both anticancer and antioxidation effects, whereas in 
high doses and delivered locally it could be cytotoxic for cancer cells. In this paper, curcumin 
microemulsions were formed with food-grade chemicals, including soybean lecithin, soybean oil, 
and Tween 80, a Food and Drug Administration-approved surfactant. The optimized composi-
tion formed curcumin microemulsions with a mean size of 40–50 nm, carrying a concentration 
of curcumin as high as 15 µM. The stability of curcumin microemulsions refrigerated at 5°C 
over at least 968 days was assessed by size distribution and zeta potential. The effects of low-
frequency ultrasound on two oral squamous cell carcinoma cell lines (OSCC-4 and OSCC-25), 
and the synergy between treatment with curcumin microemulsions and low-frequency sonic 
stimulation, were tested. Finally, microscopic imaging of the cells confirmed the toxic effects 
of the curcumin microemulsions, showing damaged and ruptured cells after treatment. Brief 
exposure to the curcumin-containing microemulsions did have cytotoxic effects, but the addition 
of ultrasound strongly enhanced those effects, especially on OSCC-25 cells.
Keywords: oral squamous cell carcinoma (OSCC), curcumin, microemulsion, ultrasound, 
controlled release
Introduction
Traditional natural products have recently been extensively examined because they 
show few side effects and have powerful antioxidation, anti-inflammation, and cancer-
preventing properties.1 For example, half a century ago, curcumin and its family of 
related compounds were reported to have antibacterial effects, and many researchers 
have subsequently studied their antioxidation and anticancer properties. However, the 
curcumin compounds are polyphenols and may not be very stable or soluble in water.2 
They have been delivered orally, using a transdermal patch, and by injection.3   Numerous 
formulations of curcumin have recently been developed, including, for example, 
solid lipid curcumin particles,4 curcumin submicrometer dispersions,5 poly(ethylene 
glycol)-magnetic nanoparticles-curcumin,6 curcumin poly  (n-butylcyanoacrylate) 
nanoparticles,7 self-microemulsifying liquid and pellets of curcumin,8 curcumin poly-
vinylpyrrolidone nanoparticles,9 and liposome-  encapsulated curcumin.10 Carriers with 
high curcumin encapsulation, low cost, and high   biocompatibility may be attractive 
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for dietary supplements, cancer prevention, and anticancer 
applications.
Plasma antioxidant activities of curcumin have 
been   measured to determine the bioavailability in 
  Sprague-Dawley rats, using self-microemulsifying liquid 
and pellet   formulations of liposome-encapsulated curcumin,8 
and male Wistar-strain rats. Curcumin poly(n-butylcyano-
acrylate) nanoparticles have also been used to investigate 
the penetration of the blood–brain barrier in mice, with a 
view to treating Alzheimer’s disease and to preventing the 
  formation of brain tumors.7 The in vitro antihepatoma activi-
ties of curcumin polyvinylpyrrolidone nanoparticles have 
also been investigated.9
A new generation of targeted drug carriers is beginning 
to exploit nanotechnology to reduce systemic overdosage of 
drugs,11 by supplying an effective concentration locally at the 
site of disease. Maintenance of the proper concentration of 
bioactive molecules and targeting to disease sites may both be 
improved using an external means to supply energy (such as 
a magnetic field,12 light,13 or sound waves14,15). The possibility 
presents itself that locally delivered curcumin might be an 
effective cancer treatment. Local   concentrations could, in 
principle, be sufficient to kill tumor cells, and the antioxidant 
effects of curcumin would be beneficial to nearby nontumor 
cells. We have chosen to study ultrasound as a potential 
release modality for a lipid-based (here, a lipid emulsion) 
carrier. Ultrasound has been fairly extensively studied and can 
provide a “direct” release mechanism or act via local hyper-
thermia to enhance the delivery of   specific formulations, as 
described previously. Incorporation of poly(ethylene glycol)-
containing surfactants appears to enhance the sensitivity of 
lipid-based carriers to sound,16 possibly by interfering with 
the “healing” of membrane defects. Emulsions are drawing 
increased attention, and so-called phase-shift emulsions (gen-
erally containing low boiling point fluorocarbons) can give 
ultrasound-triggered release when emulsion droplets vapor-
ize in response to insonation.17 Ganta and Amiji18 have used 
a combination of paclitaxel and curcumin in nanoemulsion 
formulations to overcome multidrug resistance in SKOV3TR 
ovarian adenocarcinoma cells.
This investigation considers the stability and effects 
of low-frequency ultrasound on a curcumin microemul-
sion.15 A carrier oil was used to solubilize the curcumin. 
Soybean oil (listed as generally recognized as safe) was 
used, rather than ethyle oleate, which is not currently 
approved by the Food and Drug Administration for any 
injectable use and is regulated as a food additive. The sound 
intensity required to release curcumin from the curcumin   
microemulsions to two oral squamous carcinoma cell lines 
(OSCC-4 and OSCC-25) was also examined. Finally,   dosages 
and the synergy between ultrasound and curcumin micro-
emulsions were studied to determine the efficacy of this 
method for the localized delivery of curcumin.
Materials and methods
Lipids and chemicals
Soybean lecithin (L-α-phosphatidylcholine and inositol 
phospholipids, purity . 80%) (sourced from natural plant 
soybean oil) and soybean oil were obtained from Taiwan 
Sugar Corporation (Tainan, Taiwan) and Uni-President 
Corporation (Tainan), respectively. Both are food-grade 
products. Tween 80 and curcumin powder of 70% purity 
were purchased from Sigma-Aldrich Chemical Co (St Louis, 
MO) and Fluka (Seelze, Germany). OSCC-4 and OSCC-
25 cell lines (#60142 and #60516) were purchased from 
  Bioresource Collection and Research Center (Hsinchu, 
  Taiwan). The culture medium for OSCC cell lines contains 
44% of both   Dulbecco’s modified Eagle’s medium and Ham’s 
F12 medium, 2.5 mM L-glutamine, 15 mM HEPES (powder 
from Gibco), 1.2 g/L sodium bicarbonate, 10% fetal bovine 
serum, 1% nonessential amino acid (Invitrogen, Carlsbad, 
CA), and 1% penicillin/streptomycin. The last three chemi-
cals are also from Sigma-Aldrich Chemical Co.   Dimethyl 
sulfoxide (DMSO, product #161954) was purchased from 
Panreac (Barcelona, Spain).
Preparation of curcumin microemulsions
Deionized water, soybean oil, soybean lecithin, and Tween 
80 as surfactants, and curcumin, in amounts   indicated in 
Figure 1 (vide infra), were placed in a test tube (10 mm × 120 mm) 
and well mixed at 50°C using a   vortex mixer at 100 rpm 
for 5–20 minutes to form curcumin   microemulsions. The 
curcumin microemulsion had a transparent appearance with 
a yellow tint.
Stability of curcumin microemulsions 
measured by size distribution and zeta 
potential
The size distribution and zeta potential of curcumin 
  microemulsions were studied with a particle sizer and a 
zeta potential analyzer (90Plus and ZetaPlus, Brookhaven 
  Instruments Co, New York, NY), equipped with a 532 nm laser 
light source. The scattering laser power of this i  nstrument is 
the standard 35 mW laser but adjusted to 25 mW. The 90Plus 
particle sizer uses dynamic light   scattering, with   collection 
times for the autocorrelation function of 1–3   minutes at the 
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90° scattering angle. The average count rate of the background 
was 3 kcps, and that of each measurement was between 20 
kcps and 500 kcps. The correlator covers the equivalent of 107 
linearly spaced channels. Real-time operation over the entire 
delay-time range corresponding to particle sizes between 
1 nm and 6000 nm was chosen.
It is also important to assess whether microemulsions 
are sufficiently stable in the presence of serum proteins. 
For this purpose, a solution of (bovine serum) albumin was 
prepared at 5 mg/mL in phosphate buffered saline (PBS) 
solution at pH 7.4. Curcumin microemulsion in amounts 
of 0.1 mL, 0.2 mL, 1 mL, and 2 mL was added into 5 mL 
  albumin solution, and emulsion sizes were measured 0–7 days 
after preparation.
Curcumin release from microemulsions 
under insonation
The 40 kHz ultrasonic processor (Model VC134, Sonics 
and Materials Inc, Newtown, CT) with a “standard” probe 
(Ti-6 Al-4V) of 3 mm diameter was immersed into a 1 cm 
polystyrene cuvette. The probe was immersed approxi-
mately 1 cm into a 1.5 mL sample, initially containing 
only PBS (65 mM NaCl and 50 mM KH2PO4 at pH 7.4). 
After adding 300 µL of microemulsion stock solution (to 
a dilution of 6× ), ultrasound was then applied at either 
20% (∼1.9 W/cm2) of full power for 5 seconds, 10 seconds, 
15 seconds, and 20   seconds. Released curcumin forms 
insoluble aggregates, which float to the surface of the 
sample. The resultant solution was passed through a 0.45 µm 
filter and then subjected to high-pressure liquid chromatog-
raphy19 (Hitachi L-2130 pump, L-2420 UV/VIS detector, 
and LiChrospher 100–5 R C-18 column). The separation 
was performed on a Cosmosil 5C18 MS column (5 µm, 
25 cm × 4.6 mm ID, Nacalai Tesque, Kyoto, Japan). The 
sample (20 µL) was eluted with a mobile phase composed 
of 0.1% H3PO4 (40%) and acetonitrile (60%). The flow rate 
and detection wavelength were set to be 1.0 mL/minute and 
420 nm, respectively.20 The standard curves of curcumin 
in DMSO ranging from 0.01 mg/mL to 1.0 mg/mL were 
used for calibration. The retention time for curcumin is 
12.3 minutes.
The droplet morphologies of the curcumin   microemulsions 
were determined using transmission electron microscopy 
(TEM). A total of 5 µL of curcumin microemulsion was 
placed on 200 mesh formvar carbon-coated copper grids 
for 10 minutes, and then negative stained with 5 µL of 
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Figure 1 Stability of emulsions made from oil (soybean oil plus curcumin)/water/surfactants (lecithin plus Tween 80), stored at 25°C. Microemulsions shown as open circles 
were found to be stable; (×): microemulsions were unstable. 
Note: Tween 80:lecithin ratios were varied from 1:1 to 24:1, with no significant change in microemulsion stability with the same total surfactant.
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2% uranyl acetate for 10 minutes at room temperature. 
The excess liquid on the samples was wiped off with a filter 
paper, and then samples were air-dryed for 30 minutes. The 
grid   containing the microemulsion droplets was observed 
with a field emission scanning electron microscope   (FE-SEM) 
S-4800 (Hitachi, Japan) and TEM H-7500 (Hitachi).
MTT (cytotoxicity) test of OSCC 
with curcumin microemulsions after 
insonation
The MTT test (97.50% purity from Sigma-Aldrich Chemical 
Co) is used as a rapid and sensitive method for screening 
curcumin microemulsions and ultrasound effects on OSCC-4 
and OSCC-25 cells. About 2 × 104 OSCC cells were added 
to the 96-well culture plate (Nalge Nunc International, 
  Rochester, NY) and incubated (37°C and 5% CO2) for 
24 hours. A total volume of 30 µL, consisting of differing 
amounts of curcumin microemulsion and PBS, was added. 
Samples were insonated and then incubated for another 
24 hours. MTT solution (50 µL) was added to each well 
and incubated with cells for 3 hours. Medium was removed 
and 100 µL DMSO was added. Absorption at signal and 
reference wavelengths (570 nm and 620 nm, respectively) 
was measured with an ELISA reader (Power Wave HT340, 
BioTek, Winooski, VT). Effective absorption is obtained by 
subtracting the reference absorption from the signal. The 
cellular viability (%) was then calculated from the ratio of 
effective absorption of experimental cells to controls. The 
temperature was measured after insonation using the dual 
input digital thermometer DTM 315 (Tecpel Co, Taiwan).
All data were analyzed by Student’s t-test using SPSS 
statistics software (SPSS, Inc, Chicago, IL).
Results and discussion
Microemulsions are good candidate drug carriers because 
of their nanometer size, which enhances the kinetics of 
drug absorption/desorption and may also increase the load-
ing capacity for surface active drugs.21 In addition, small 
size allows passage through organ filtering systems, and 
extravasation through tumor vasculature, both of which are   
highly desirable characteristics. Most anticancer drugs 
are hydrophobic or amphiphilic, and micelle carriers may 
encapsulate much higher concentrations of a drug than 
other carriers. In this paper we have focused on emulsions 
of soybean oil in water as carriers for a potentially useful 
anticancer agent, curcumin.
Figure 1 shows the compositions for which we obtained 
stable oil-in-water microemulsions. Unstable formulations 
rapidly separate into water and oil phases that can be   visually 
observed. The stable microemulsions contain oil and surfactant 
concentrations of less than ∼8 wt% and 30 wt%, respectively. 
To carry more drugs in the   microemulsions, the oil content 
must be as high as possible, but increasing the   concentration 
of oil may cause instability and require that more surfactants 
be used, increasing total cost.   Microemulsions that contained 
2.5 wt% oil and 15 wt% surfactants were chosen to be used 
in an in vitro test with the OSCC cell lines, with curcumin 
dissolved in the oil phase to 0.27 mg/mL, the highest con-
centration that is fully soluble. As the oil-water partition 
coefficient of curcumin is ∼2000, almost all of the curcumin 
should remain in the microemulsion droplets. The total con-
centration of emulsified curcumin was 15 µM.
Figure 2A displays the stability in the size and zeta 
potential of these microemulsions. Light scattering measure-
ments of the mean size of the curcumin microemulsions gave 
41 ± 3 nm to 51 ± 2 nm, measured at various times during a 
968-day storage at 5°C. The zeta potential exhibits good to 
moderate stability after 968 days of storage, though there is 
a small but statistically significant decrease in zeta potential 
over 40 days, from −42.12 ± 1.26 mV to −32.58 ± 3.89 mV . 
This negative zeta potential arises from the incorporation of 
lecithin in the microemulsion, as lecithin micelles/suspensions 
were also found to have zeta potential, from −36.2 ± 2.7 mV 
to −59.9 ± 3.8 mV . Although there is some change in the 
size and zeta potential over long periods, these changes are 
small and do not necessarily indicate that these emulsions are 
“unstable.” In practice, emulsions are considered “moderately 
stable” if the magnitude of the zeta potential exceeds 30 mV 
(American Society for Testing and Materials standard),19–21 as 
zeta potentials this large strongly inhibit coalescence.
For potential applications of microemulsions in drug 
delivery, the stability of the microemulsion in the presence 
of serum proteins is critical. We measured the stabilities of 
these curcumin-encapsulated microemulsions after dilution 
into a 5 mg/mL albumin solution by measuring droplet size, 
after storage in the dark for 0–7 days, as shown in Figure 2B. 
Although there was a slight decrease in the measured droplet 
size, there was no evidence of droplet coalescence, ripening, 
or gross instability.
Figure 3 shows the effects of ultrasound on newly   prepared 
curcumin microemulsions. The mean particle size decreased 
dramatically when ultrasound was applied even for only a 
few seconds, from 44 ± 3 nm to 26 ± 2 nm in 20 seconds 
when insonated at 20% of full power at 40 kHz (Figure 3). 
The light scattering polydispersity index (an   estimate of the 
width of the distribution) of the curcumin   microemulsion 
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was 0.327–0.331, regardless of the application of ultrasound, 
which is considered a moderate   polydispersity. Sixty-six 
percent of the microemulsion particles are within ±9–14 nm 
of the light scattering peak size. Figure 3B shows that the 
magnitude of the zeta potential decreased slightly, from 
−42.12 ± 1.26 mV to −34.29 ± 1.82 mV, on insonation. 
Absorption measurements showed that the micellized cur-
cumin concentration decreased from 15.0 µM to 12.5 µM 
(released curcumin is insoluble and forms a floating aggregate 
out of the ultraviolet-visible probe beam). The decrease in 
particle size may be related to the well-known breakup of 
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bubbles in ultrasound, which can occur through the parametric 
amplification of surface modes.22,23 It is less clear why droplet 
breakup leads to release and aggregation of curcumin, but 
it is certainly plausible that the increased surface exposure 
(caused by dilution of surfactants on the increased surface 
area of smaller droplets) causes curcumin aggregation, or that 
curcumin exposure to the aqueous phase is transiently elevated 
at droplet fission necks or other transient structures.
Figure 4 demonstrates that simply immersing the   ultrasonic 
probe into the cell well has no effect on cell   viabil  ity, as 
expected. In the absence of microemulsions, ultrasound 
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applied at the 20% power setting gave good cell viability until 
20 seconds of insonation, for both cell lines (Figure 4A and B, 
circles). (Because of the rather long wavelength of this low-
frequency 40 kHz ultrasound, all cells in a well [in the 96-well 
plate] should experience approximately the same sound field.) 
The rather unusual dose response, with essentially no effects 
after ,20 seconds of exposure, suggests that an indirect ultra-
sound effect, such as a temperature rise greater than 4.2° (in 
Figure 4C), may actually be the cause of the loss of viability 
after 20 seconds of exposure. Higher intensities of ultrasound 
caused cell viability to drop after shorter exposures. For $40% 
of full power, only 2 seconds of exposure was sufficient to kill 
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Figure 4 The MTT viability test results on (A) oral squamous cell carcinoma-4 and (B) oral squamous cell carcinoma-25 cells after different insonation duration, in buffer 
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essentially all the cells. At 30% of full power, cell viability 
decayed more gradually with increasing exposure.
Figure 5A shows that the size distribution of microemul-
sion droplets shifts to smaller sizes on applying ultrasound 
from 0 seconds to 20 seconds. The uranyl acetate negative stain 
enhances contrast. The FE-SEM (insert) and TEM show the 
spherical morphology of the microemulsion droplets without 
ultrasound (Figure 5B). After 10 seconds of ultrasound, the 
sample floating to the surface was picked up on an electron 
microscope grid and imaged. The FE-SEM image (Figure 5C) 
shows that the released curcumin in   soybean oil is aggregated, 
with a droplet size larger than that of microemulsion droplets.
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concentration studies (15 µΜ), only in the presence of 
ultrasound, and only on the OSCC-25 cell line. Unlike free 
curcumin or curcumin in DMSO, curcumin microemulsions 
are toxic to cells (Figure 6, open symbols). This toxicity may 
be a consequence of the increased delivery of curcumin to 
the cell, perhaps via fusion of microemulsion droplets with 
cell membranes. When 40 kHz ultrasound (power level 
20%, ∼1.9 W/cm2) is applied for 20 seconds, the cytotoxic 
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Figure 6 Viability (via MTT test) of cells after treatment with different concentrations 
of curcumin-containing microemulsions. Cells in 96-well plates were treated with 
different dilutions (in phosphate buffered saline) of a 15 µM curcumin microemulsion, 
then exposed or not to ultrasound (US) at 20% power level for 20 seconds: (A) oral 
squamous cell carcinoma (OSCC)-4 and (B) OSCC-25 cell lines. 
Note: The OSCC-25 cell line had a decrease of about a factor of six in the LD50 
for the microemulsion.
Likely owing to its near complete insolubility in water, 
curcumin alone has no statistically significant effect on 
cell survival or growth, in either the presence or absence 
of ultrasound for 20 seconds at 20% full power (data not 
shown). When curcumin was first dissolved in DMSO and 
then dispersed into cell cultures, a small reduction in cell 
growth (25%) was seen, but only at the highest curcumin 
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effects of the curcumin microemulsions are enhanced (solid 
symbols). The enhancement is particularly dramatic for the 
OSCC-25 cells, for which the LD50 dropped from about 
6 µM to 1 µM. To evaluate the statistical significance of 
the viability change in each cell line, the data at each cur-
cumin concentration were compared using Student’s t-test. 
On OSCC-4 cells, the effect at each concentration has rather 
weak statistical significance (especially when error bars 
overlap, eg, at 3 µM, 5 µM, and 10 µM curcumin). However, 
the probability of the null hypothesis (ie, that ultrasound 
has no effect on viability) is obtained as the product of the 
individual P-values for the points and is ,0.008. Thus, there 
is a small but statistically significant effect of ultrasound 
on enhancing the cytotoxicity of curcumin microemulsion. 
At most curcumin concentrations, the cytotoxicity increased 
by .25% for the OSCC-4 cells.
The effect of ultrasound on the OSCC-25 cell line had 
even greater statistical significance (P , 0.002) when 
  analyzed by Student’s t-test (Figure 6B). Note that exposure 
of cells to microemulsions without curcumin, for this length 
of time, is not toxic.
In liposomally based ultrasound delivery, a threshold in 
sound intensity for efficacy has been reported,15,24 which 
likely indicates that ultrasound-induced cavitation is required. 
Interestingly, the intensities that are effective with curcumin 
microemulsions range from below cavitational to well above 
it. The higher intensities (such as are shown in Figure 4B 
and 4B, $30% maximum power) are lethal to cells even at 
the briefest exposures studied and likely cause cavitation, 
whereas the 20% power setting gave no measurable cell 
death for short exposures. (The 20% power setting on this 
  sonicator probe provides 1.9 W/cm2, which is below the 
typical cavitation threshold; moreover, the identical sonicator 
had no effects on liposomes at this power level, implying a 
lack of cavitation.)
Our results imply that ultrasound is enhancing the 
  delivery of cytotoxic concentrations of curcumin to cells. 
Ultrasound-enhanced delivery at subcavitating intensities is 
not unprecedented; effects on drug release from micelles has 
been reported, for example.25 It is interesting and noteworthy 
that ultrasound caused directly measurable changes in emul-
sion droplet size and loss of dissolved curcumin, as we show 
in Figure 3B, though of course we cannot be certain that such 
release of curcumin is in fact a prerequisite to the ultrasound-
mediated delivery to the cells. It is always possible that direct 
contact between cells and microemulsion droplets, followed 
by insonation, leads to the fusion of a droplet with the cell 
and delivery of the curcumin cargo.
Figure 7 displays optical microscopy images of 
OSCC-25 cells with curcumin concentrations (from top 
to   bottom: 0 µM, 5 µM, 10 µM, and 15 µM) without 
(left column) and with sonication (right column). As can be seen 
from the microscope images, higher curcumin concentrations 
induce greater cellular lysis. For a particular applied   curcumin 
concentration, ultrasound enhanced the toxicity effect and fewer 
cells are observed, as in Figure 7D and H.
Figure 8 highlights the synergistic effects of   curcumin-
containing microemulsions and ultrasound. Shown are cell 
viabilities for cells treated with curcumin-free microemulsions 
without ultrasound, curcumin-free microemulsions and 
ultrasound (20 seconds at 20% power, ∼1.9 W/cm2), curcumin-
containing microemulsions without ultrasound, and curcumin-
containing microemulsions with the low-intensity ultrasound 
treatment. Adding the curcumin-free microemulsion into 
OSCC cell lines, the “viabilities” of OSCC-4 and OSCC-25 
cell lines were actually increased to .100% by sonication. 
(Viabilities . 100% simply reflect that more live, healthy 
cells were counted after treatment than before.) This clearly 
shows that microemulsions alone are not harmful to the 
cells. The increased cell growth is consistent with previous 
reports that low-intensity ultrasound can sometimes enhance 
cell metabolism and proliferation.26,27 Brief exposure to the 
curcumin-containing microemulsions did have cytotoxic 
effects, but the addition of ultrasound strongly enhanced 
those effects, as shown in Figure 8. Continuous low-frequency 
sound waves effectively induced the release of curcumin from 
microemulsions. A lower-intensity (about 20% of full power) 
and shorter sonication duration (∼20 seconds) does not damage 
OSCC-4 and OSCC-25 cells, as determined by monitoring 
24 hours after application of the sound, but did enhance the 
toxicity of the curcumin-containing microemulsions. With the 
OSCC-25 cell line, the LD50 was reduced by about a factor 
of six. Comparison of the expression of fatty acid synthase28 
and activated transforming growth factor-ß1 signaling29 has 
shown that OSCC-25 is a more aggressive tumor cell line than 
OSCC-4. These differences may be related to the differential 
efficacy of ultrasound on the two lines.
The increased cytotoxicity of curcumin microemulsions 
in the presence of ultrasound could arise from an enhanced 
fusion of microemulsion droplets to cell membranes, 
or simply from amelioration of transport limitations by 
  ultrasound-induced mixing and/or heating. It is notewor-
thy that enhancements were seen even for 5 seconds of 
ultrasound exposure, which argues against a simple heat-
ing mechanism (as temperature increases with duration of 
exposure).
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Figure 7 Optical microscope images of oral squamous cell carcinoma-25 cell lines stained by trypan blue; (A–D) show the microscopic images of cells with curcumin 
concentrations at 0 µM, 5 µM, 10 µM, and 150 µM without sonication, and (E and H) show the microscopic images of cells with curcumin concentrations at 0 µM, 5 µM, 
10 µM, and 15 µM after sonication treatment. 
Note: Those images show the synergy of microemulsion treatment with ultrasound in producing cytotoxicity.
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usable in this kind of application.   Moreover, the ingredients 
are all biocompatible, to reduce the side effects. The stable 
microemulsions were characterized by their mean droplet size 
and zeta potential, and these were found to be fairly stable after 
968 days in a freezer. The effect of sound on the release of 
curcumin may help to maintain the effective concentration for 
the chemotherapy, especially for the more aggressive cell lines 
(eg, OSCC-25). Additionally, the in vitro controlled release 
of drugs (thought of as simply bioactive molecules) may be 
useful in cellular molecular therapy in tissue engineering.
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